Project acronym AMYTOX
Project Amyloid fibril cytotoxicity: new insights from novel approaches
Researcher (PI) Sheena Radford
Host Institution (HI) UNIVERSITY OF LEEDS
Call Details Advanced Grant (AdG), LS1, ERC-2012-ADG_20120314
Summary Despite the discovery of amyloidosis more than a century ago, the molecular and cellular mechanisms of these devastating human disorders remain obscure. In addition to their involvement in disease, amyloid fibrils perform physiological functions, whilst others have potentials as biomaterials. To realise their use in nanotechnology and to enable the development of amyloid therapies, there is an urgent need to understand the molecular pathways of amyloid assembly and to determine how amyloid fibrils interact with cells and cellular components. The challenges lie in the transient nature and low population of aggregating species and the panoply of amyloid fibril structures. This molecular complexity renders identification of the culprits of amyloid disease impossible to achieve using traditional methods.
Here I propose a series of exciting experiments that aim to cast new light on the molecular and cellular mechanisms of amyloidosis by exploiting approaches capable of imaging individual protein molecules or single protein fibrils in vitro and in living cells. The proposal builds on new data from our laboratory that have shown that amyloid fibrils (disease-associated, functional and created from de novo designed sequences) kill cells by a mechanism that depends on fibril length and on cellular uptake. Specifically, I will (i) use single molecule fluorescence and non-covalent mass spectrometry and to determine why short fibril samples disrupt biological membranes more than their longer counterparts and electron tomography to determine, for the first time, the structural properties of cytotoxic fibril ends; (ii) develop single molecule force spectroscopy to probe the interactions between amyloid precursors, fibrils and cellular membranes; and (iii) develop cell biological assays to discover the biological mechanism(s) of amyloid-induced cell death and high resolution imaging and electron tomography to visualise amyloid fibrils in the act of killing living cells.
Summary
Despite the discovery of amyloidosis more than a century ago, the molecular and cellular mechanisms of these devastating human disorders remain obscure. In addition to their involvement in disease, amyloid fibrils perform physiological functions, whilst others have potentials as biomaterials. To realise their use in nanotechnology and to enable the development of amyloid therapies, there is an urgent need to understand the molecular pathways of amyloid assembly and to determine how amyloid fibrils interact with cells and cellular components. The challenges lie in the transient nature and low population of aggregating species and the panoply of amyloid fibril structures. This molecular complexity renders identification of the culprits of amyloid disease impossible to achieve using traditional methods.
Here I propose a series of exciting experiments that aim to cast new light on the molecular and cellular mechanisms of amyloidosis by exploiting approaches capable of imaging individual protein molecules or single protein fibrils in vitro and in living cells. The proposal builds on new data from our laboratory that have shown that amyloid fibrils (disease-associated, functional and created from de novo designed sequences) kill cells by a mechanism that depends on fibril length and on cellular uptake. Specifically, I will (i) use single molecule fluorescence and non-covalent mass spectrometry and to determine why short fibril samples disrupt biological membranes more than their longer counterparts and electron tomography to determine, for the first time, the structural properties of cytotoxic fibril ends; (ii) develop single molecule force spectroscopy to probe the interactions between amyloid precursors, fibrils and cellular membranes; and (iii) develop cell biological assays to discover the biological mechanism(s) of amyloid-induced cell death and high resolution imaging and electron tomography to visualise amyloid fibrils in the act of killing living cells.
Max ERC Funding
2 498 465 €
Duration
Start date: 2013-05-01, End date: 2019-04-30
Project acronym COSMIC
Project Complex Synthetic Mimics of the Cell Membrane
Researcher (PI) Mark Ian Wallace
Host Institution (HI) KING'S COLLEGE LONDON
Call Details Starting Grant (StG), LS1, ERC-2012-StG_20111109
Summary I propose to bridge the gap between simple in vitro measurements of biological processes, and the complexities of the cellular environment. This requires reduced in vitro systems that are sufficiently complex to reproduce the subtleties of the in vivo biological phenomenon, but sufficiently controllable to test how quantitative changes in a particular property affects function. The challenge is to step beyond the most simple and straightforward in vitro mimics of the cell membrane, and create model systems that more closely reproduce the conditions in vivo.
I propose to tackle two specific, but interrelated membrane phenomena, that are currently not captured in artificial bilayers and create new complex mimics of the cell membrane capable of tackling these systems; namely (1) protein crowding and the cytoskeleton, and (2) lateral forces and membrane curvature. Testing our synthetic mimics with models that we understand in vivo is vital. This benchmarking will ensure that the mimics we create are relevant and will help ensure the more ambitious later goals of the this proposal are successful.We will then take these tools to go on and aim to create a synthetic mimic of the bacterial membrane.
However we are not limited to creating purely natural duplicates, and we can exploit a much wider range of building material than nature. In addition to creating complex mimics, we will also create totally new synthetic systems inspired by the properties of the cell membrane, but possessing unique properties.
Summary
I propose to bridge the gap between simple in vitro measurements of biological processes, and the complexities of the cellular environment. This requires reduced in vitro systems that are sufficiently complex to reproduce the subtleties of the in vivo biological phenomenon, but sufficiently controllable to test how quantitative changes in a particular property affects function. The challenge is to step beyond the most simple and straightforward in vitro mimics of the cell membrane, and create model systems that more closely reproduce the conditions in vivo.
I propose to tackle two specific, but interrelated membrane phenomena, that are currently not captured in artificial bilayers and create new complex mimics of the cell membrane capable of tackling these systems; namely (1) protein crowding and the cytoskeleton, and (2) lateral forces and membrane curvature. Testing our synthetic mimics with models that we understand in vivo is vital. This benchmarking will ensure that the mimics we create are relevant and will help ensure the more ambitious later goals of the this proposal are successful.We will then take these tools to go on and aim to create a synthetic mimic of the bacterial membrane.
However we are not limited to creating purely natural duplicates, and we can exploit a much wider range of building material than nature. In addition to creating complex mimics, we will also create totally new synthetic systems inspired by the properties of the cell membrane, but possessing unique properties.
Max ERC Funding
1 498 523 €
Duration
Start date: 2013-02-01, End date: 2018-10-31
Project acronym DNA-REPAIR-CHROMATIN
Project Biochemical reconstitution of DNA repair reactions on physiological chromatin substrates
Researcher (PI) Matthew John Neale
Host Institution (HI) THE UNIVERSITY OF SUSSEX
Call Details Starting Grant (StG), LS1, ERC-2012-StG_20111109
Summary For cells and organisms to survive and propagate, they must accurately pass on their genetic information to the next generation. Errors in this process may arise from spontaneous mistakes in normal cellular metabolism, or from exposure to external agents, such as chemical mutagens and radiation. To protect themselves from the consequences of DNA damage, cells have evolved a vast array of pathways DNA repair mechanisms, each optimised for the resolution of a particular problem. One method of DNA repair, called homologous recombination (HR), involves using intact undamaged DNA sequences as a template to repair the damaged copy. HR is used extensively in meiotic cells to repair DNA breaks that are purposely created by the cell. In this context, HR is not just a repair mechanism, but also a method to drive interaction and genetic exchange between maternally and paternally inherited chromosomes, creating haploid genomes which are chimeras of the parental genetic information. Thus, the study of DNA repair and recombination informs our understanding of mechanisms that maintain genome stability, but which also generate genetic diversity, topics that are as critical to the survival of an individual cell as they are for the evolution and survival of an entire ecosystem. In recent decades a great deal has been learned of the genetic and biochemical control of the DNA repair and recombination mechanism. In general we infer gene function from what happens (or doesn’t happen) when we mutate a pathway of interest, and use biochemistry to test function using surrogate, simplified in vitro assays. Here, to bridge the divide between these classic approaches, I propose to develop biochemical methods using intact chromatin prepared from living cells. I believe that integrating chromatin biochemistry, with cell biology and genome-wide analysis will enable a new mode of scientific investigation, detailing how molecular reactions occur on biologically-relevant chromosomal substrates.
Summary
For cells and organisms to survive and propagate, they must accurately pass on their genetic information to the next generation. Errors in this process may arise from spontaneous mistakes in normal cellular metabolism, or from exposure to external agents, such as chemical mutagens and radiation. To protect themselves from the consequences of DNA damage, cells have evolved a vast array of pathways DNA repair mechanisms, each optimised for the resolution of a particular problem. One method of DNA repair, called homologous recombination (HR), involves using intact undamaged DNA sequences as a template to repair the damaged copy. HR is used extensively in meiotic cells to repair DNA breaks that are purposely created by the cell. In this context, HR is not just a repair mechanism, but also a method to drive interaction and genetic exchange between maternally and paternally inherited chromosomes, creating haploid genomes which are chimeras of the parental genetic information. Thus, the study of DNA repair and recombination informs our understanding of mechanisms that maintain genome stability, but which also generate genetic diversity, topics that are as critical to the survival of an individual cell as they are for the evolution and survival of an entire ecosystem. In recent decades a great deal has been learned of the genetic and biochemical control of the DNA repair and recombination mechanism. In general we infer gene function from what happens (or doesn’t happen) when we mutate a pathway of interest, and use biochemistry to test function using surrogate, simplified in vitro assays. Here, to bridge the divide between these classic approaches, I propose to develop biochemical methods using intact chromatin prepared from living cells. I believe that integrating chromatin biochemistry, with cell biology and genome-wide analysis will enable a new mode of scientific investigation, detailing how molecular reactions occur on biologically-relevant chromosomal substrates.
Max ERC Funding
1 747 823 €
Duration
Start date: 2013-01-01, End date: 2018-12-31
Project acronym EVALUATE
Project Energy Vulnerability and Urban Transitions in Europe
Researcher (PI) Stefan Bouzarovski
Host Institution (HI) THE UNIVERSITY OF MANCHESTER
Call Details Starting Grant (StG), SH3, ERC-2012-StG_20111124
Summary "Millions of urban households in the post-socialist states of Eastern and Central Europe (ECE) are unable to afford heating their homes in winter due to energy price increases implementd by their governments over the past 20 years, as well as combination of wider circumstances such as cold climates, higher-than-average rates of inefficient housing, inadequately developed and/or decaying infrastructure, large income differentials and economic/political restructuring issues. The limited body of scholarship and policy tends to conceptualize domestic energy deprivation in ECE through the narrow lens of incomes and energy efficiency.
The purpose of this project is to radically transform the state of the art in the field by undertaking the first comprehensive investigation of the multiple social and spatial dimensions of energy poverty in the grain of the post-socialist city. The project will use an energy vulnerability framework to explore the causes, character and consequences of domestic energy deprivation in ECE. Energy vulnerability can be seen as the propensity of a household to experience a lack of socially- and materially-necessitated energy services in the home. EvalUaTE will investigate the manner in which institutional structures, built tissues and everyday practices shape urban energy vulnerability.
Using a combination of qualitative and quantitative methods, the project will achieve its aims by undertaking a comparative study of eight urban districts within Gdańsk (Poland), Prague (Czech Republic), Budapest (Hungary) and Skopje (FYR Macedonia). The knowledge gained from the project can potentially lead to the improvement of existing, or establishment of new, technical and institutional frameworks for the provision of affordable, clean and efficient energy services in transitioning urban areas, ultimately aiding climate change mitigation."
Summary
"Millions of urban households in the post-socialist states of Eastern and Central Europe (ECE) are unable to afford heating their homes in winter due to energy price increases implementd by their governments over the past 20 years, as well as combination of wider circumstances such as cold climates, higher-than-average rates of inefficient housing, inadequately developed and/or decaying infrastructure, large income differentials and economic/political restructuring issues. The limited body of scholarship and policy tends to conceptualize domestic energy deprivation in ECE through the narrow lens of incomes and energy efficiency.
The purpose of this project is to radically transform the state of the art in the field by undertaking the first comprehensive investigation of the multiple social and spatial dimensions of energy poverty in the grain of the post-socialist city. The project will use an energy vulnerability framework to explore the causes, character and consequences of domestic energy deprivation in ECE. Energy vulnerability can be seen as the propensity of a household to experience a lack of socially- and materially-necessitated energy services in the home. EvalUaTE will investigate the manner in which institutional structures, built tissues and everyday practices shape urban energy vulnerability.
Using a combination of qualitative and quantitative methods, the project will achieve its aims by undertaking a comparative study of eight urban districts within Gdańsk (Poland), Prague (Czech Republic), Budapest (Hungary) and Skopje (FYR Macedonia). The knowledge gained from the project can potentially lead to the improvement of existing, or establishment of new, technical and institutional frameworks for the provision of affordable, clean and efficient energy services in transitioning urban areas, ultimately aiding climate change mitigation."
Max ERC Funding
1 426 677 €
Duration
Start date: 2013-03-01, End date: 2018-02-28
Project acronym FAMHEALTH
Project "Family life courses, intergenerational exchanges and later life health"
Researcher (PI) Emily Marjatta Dorothea Grundy
Host Institution (HI) LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE
Call Details Advanced Grant (AdG), SH3, ERC-2012-ADG_20120411
Summary "The overall aim of this research programme is to uncover how family life courses influence health and well-being in later adulthood, whether family related strengths or disadvantages relevant to health offset or compound socio-economic sources of disadvantage, and the extent to which these associations are influenced by societal factors. An important element will be to consider the role of intergenerational influences, including support flows. The geographical focus will be on Europe and the methodological focus on the advanced quantitative analysis of large scale longitudinal data sets. These data sets, chosen for their complementary strengths, will include both country specific and cross national sources. Three major interlinked strands of work will be undertaken. These will focus on 1) Impacts of parenting and partnership histories on health and mortality in mid and later life. 2) Intergenerational support exchanges: demographic, cultural and policy influences and effects on health of both providers and receivers. 3) An over arching theme to be addressed in the above strands and consolidated in the third is how investments in family and social networks are related to socio-economic disparities in later life health and mortality. The programme is will bring together perspectives from a range of disciplines to address issues of great relevance to current policy challenges in Europe. It is challenging because of the problem of dealing with issues of health selection and possible bias arising from various kinds of missing data which will require methodological care and innovation. Results will contribute to the development of theory, the development of methods and provide substantive knowledge relevant to the health and well-being of older Europeans."
Summary
"The overall aim of this research programme is to uncover how family life courses influence health and well-being in later adulthood, whether family related strengths or disadvantages relevant to health offset or compound socio-economic sources of disadvantage, and the extent to which these associations are influenced by societal factors. An important element will be to consider the role of intergenerational influences, including support flows. The geographical focus will be on Europe and the methodological focus on the advanced quantitative analysis of large scale longitudinal data sets. These data sets, chosen for their complementary strengths, will include both country specific and cross national sources. Three major interlinked strands of work will be undertaken. These will focus on 1) Impacts of parenting and partnership histories on health and mortality in mid and later life. 2) Intergenerational support exchanges: demographic, cultural and policy influences and effects on health of both providers and receivers. 3) An over arching theme to be addressed in the above strands and consolidated in the third is how investments in family and social networks are related to socio-economic disparities in later life health and mortality. The programme is will bring together perspectives from a range of disciplines to address issues of great relevance to current policy challenges in Europe. It is challenging because of the problem of dealing with issues of health selection and possible bias arising from various kinds of missing data which will require methodological care and innovation. Results will contribute to the development of theory, the development of methods and provide substantive knowledge relevant to the health and well-being of older Europeans."
Max ERC Funding
1 423 110 €
Duration
Start date: 2013-07-01, End date: 2018-06-30
Project acronym GLYCOPOISE
Project Glycosylation: Programmes for Observation, Inhibition and Structure-based Exploitation of key carbohydrate-active enzymes
Researcher (PI) Gideon John Davies
Host Institution (HI) UNIVERSITY OF YORK
Call Details Advanced Grant (AdG), LS1, ERC-2012-ADG_20120314
Summary The development of new approaches to dissect the diverse roles for carbohydrates in living cells is a major challenge for modern cell biology. The huge diversity of carbohydrates is reflected in a multiplicity of function; in addition to acting as energy sources, carbohydrates play major roles in structure, signalling and epigenetics. The work programme will build upon the applicant’s excellence in the mechanistic and structural enzymology of carbohydrate-active enzymes to tackle the key challenges of modern cellular glycobiology. Our vision is to provide fundamental structural and mechanistic-dissection of key proteins and their complexes and to use these as the foundation to deliver enzyme inhibitors as tools to probe the cellular function of specific glycans. The programme’s three strands will each scale a major pinnacle of carbohydrate biochemistry. Strand 1 will focus on mammalian glycosidases involved in glycocerebroside metabolism and genetic disease. We will unlock new 3-D information for glycocerebrosidase 2 (GBA2) and use these together with GBA1 to design and exploit novel and specific enzyme inhibitors as mechanistic and cellular probes, novel chaperones and imaging agents. Strand 2 will focus on the key endoplasmic reticulum enzyme endomannosidase, both its mechanistic novelty and its exploitation to perturb cellular glycans to unlock its biological roles and deliver compounds for anti-viral therapeutics. Strand 3 will probe the modification and elaboration of specific human N-glycans and their role in cell surface receptor biology. It will focus on the GlcNAc transferase V catalysed formation of polylactosamine epitopes and their regulation of growth factor signalling at the cell surface both in health and cancerous tissues. GlycoPOISE will both answer cardinal structural and chemical mechanistic questions in the enzymology of glycobiology and inform strategies for the observation and inhibition of carbohydrate-active enzymes and their exploitation
Summary
The development of new approaches to dissect the diverse roles for carbohydrates in living cells is a major challenge for modern cell biology. The huge diversity of carbohydrates is reflected in a multiplicity of function; in addition to acting as energy sources, carbohydrates play major roles in structure, signalling and epigenetics. The work programme will build upon the applicant’s excellence in the mechanistic and structural enzymology of carbohydrate-active enzymes to tackle the key challenges of modern cellular glycobiology. Our vision is to provide fundamental structural and mechanistic-dissection of key proteins and their complexes and to use these as the foundation to deliver enzyme inhibitors as tools to probe the cellular function of specific glycans. The programme’s three strands will each scale a major pinnacle of carbohydrate biochemistry. Strand 1 will focus on mammalian glycosidases involved in glycocerebroside metabolism and genetic disease. We will unlock new 3-D information for glycocerebrosidase 2 (GBA2) and use these together with GBA1 to design and exploit novel and specific enzyme inhibitors as mechanistic and cellular probes, novel chaperones and imaging agents. Strand 2 will focus on the key endoplasmic reticulum enzyme endomannosidase, both its mechanistic novelty and its exploitation to perturb cellular glycans to unlock its biological roles and deliver compounds for anti-viral therapeutics. Strand 3 will probe the modification and elaboration of specific human N-glycans and their role in cell surface receptor biology. It will focus on the GlcNAc transferase V catalysed formation of polylactosamine epitopes and their regulation of growth factor signalling at the cell surface both in health and cancerous tissues. GlycoPOISE will both answer cardinal structural and chemical mechanistic questions in the enzymology of glycobiology and inform strategies for the observation and inhibition of carbohydrate-active enzymes and their exploitation
Max ERC Funding
2 500 000 €
Duration
Start date: 2013-05-01, End date: 2019-04-30
Project acronym HRES
Project Health Resilience and Economic Shocks: Analysis of Quasi-Natural Experiments Using Multi-Level Modelling
Researcher (PI) David Stuckler
Host Institution (HI) THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Call Details Starting Grant (StG), SH3, ERC-2012-StG_20111124
Summary "One of the greatest contemporary challenges for the social sciences is to understand the human costs of the ongoing financial, economic, and debt crises that began to emerge in Europe in 2007. While much attention has focused on the economic dimensions of recessions in Europe, very little work is being done to analyse the consequences of these events for health and well-being. There are widespread concerns that losses of housing, jobs, and income will have damaging effects on public health. Curiously, however, a growing body of social science research suggests that economic recessions may reduce death rates at a population level, such as by lowering the number of road-traffic injuries, alcohol-related deaths and hospital admissions. Hence, although there is universal agreement that economic shocks will affect health, there is considerable confusion about what the direction of this relationship is. This project aims to understand two interrelated questions: How will the recent economic downturns affect health in Europe? What can be done to mitigate potential negative consequences for health from these economic shocks? To answer these questions, the proposed research will draw on a secondary analysis of longitudinal household datasets and country-level economic and health data to estimate how job loss, poverty, debt, and housing foreclosures affect health. Then, drawing on a conceptual model of ‘resilience’, the project will seek to understand why certain groups have experienced better or worse health outcomes than others in the context of recession. These studies will extend the authors’ initial case studies of mortality in Europe revealing a rapid increase in suicide rates, albeit with marked variations across countries, linked to the financial crises of 2007. The research will have important implications for policymakers seeking to protect health from ongoing economic risks and budget cuts, especially as recovery is projected to evolve slowly over the next decade."
Summary
"One of the greatest contemporary challenges for the social sciences is to understand the human costs of the ongoing financial, economic, and debt crises that began to emerge in Europe in 2007. While much attention has focused on the economic dimensions of recessions in Europe, very little work is being done to analyse the consequences of these events for health and well-being. There are widespread concerns that losses of housing, jobs, and income will have damaging effects on public health. Curiously, however, a growing body of social science research suggests that economic recessions may reduce death rates at a population level, such as by lowering the number of road-traffic injuries, alcohol-related deaths and hospital admissions. Hence, although there is universal agreement that economic shocks will affect health, there is considerable confusion about what the direction of this relationship is. This project aims to understand two interrelated questions: How will the recent economic downturns affect health in Europe? What can be done to mitigate potential negative consequences for health from these economic shocks? To answer these questions, the proposed research will draw on a secondary analysis of longitudinal household datasets and country-level economic and health data to estimate how job loss, poverty, debt, and housing foreclosures affect health. Then, drawing on a conceptual model of ‘resilience’, the project will seek to understand why certain groups have experienced better or worse health outcomes than others in the context of recession. These studies will extend the authors’ initial case studies of mortality in Europe revealing a rapid increase in suicide rates, albeit with marked variations across countries, linked to the financial crises of 2007. The research will have important implications for policymakers seeking to protect health from ongoing economic risks and budget cuts, especially as recovery is projected to evolve slowly over the next decade."
Max ERC Funding
1 358 013 €
Duration
Start date: 2013-10-01, End date: 2018-09-30
Project acronym METABOp53
Project Metabolic functions of p53 in non-cancer pathologies
Researcher (PI) Karen Vousden
Host Institution (HI) BEATSON INSTITUTE FOR CANCER RESEARCH LBG
Call Details Advanced Grant (AdG), LS1, ERC-2012-ADG_20120314
Summary Extensive study of the p53 protein has resulted in a detailed understanding of its role in tumour suppression, information that is being used to develop small molecule modulators of p53 that are presently under evaluation for cancer therapy. However, it has recently become clear that p53 also plays roles in aspects of human health and disease extending beyond cancer - although most of these are poorly understood. We therefore propose to investigate some of these non-cancer functions of p53, with an emphasis on the role of p53 in the regulation of metabolism, extending to an analysis of whether p53 contributes to pathologies such as diabetes and obesity. This is a pioneering project that brings p53 research into new areas, yet builds on the solid platform of existing knowledge about the regulation and function of p53. State of the art genomic, proteomic, metabolomic and imaging analyses will be used to identify the roles of p53 in the response to metabolic stress caused by nutrient deficiency or excess, and investigate how these activities balance cell survival and cell death. Models will be developed to address how these functions of p53 relate to the control of metabolism and disease in vivo. Understanding how the cellular response to metabolic stress is controlled, and identifying a role for p53 in the regulation of metabolic homeostasis has enormous potential to influence the diagnosis and treatment of disease. The proposal will help to define the role of p53 in the development of diabetes and obesity, and lay the groundwork for the investigation of a role for p53 in other pathologies, such as neurodegenerative disease, cardiovascular disease and liver disease. These studies will therefore have far-reaching impact on some of the most prominent health threats in the developed world.
Summary
Extensive study of the p53 protein has resulted in a detailed understanding of its role in tumour suppression, information that is being used to develop small molecule modulators of p53 that are presently under evaluation for cancer therapy. However, it has recently become clear that p53 also plays roles in aspects of human health and disease extending beyond cancer - although most of these are poorly understood. We therefore propose to investigate some of these non-cancer functions of p53, with an emphasis on the role of p53 in the regulation of metabolism, extending to an analysis of whether p53 contributes to pathologies such as diabetes and obesity. This is a pioneering project that brings p53 research into new areas, yet builds on the solid platform of existing knowledge about the regulation and function of p53. State of the art genomic, proteomic, metabolomic and imaging analyses will be used to identify the roles of p53 in the response to metabolic stress caused by nutrient deficiency or excess, and investigate how these activities balance cell survival and cell death. Models will be developed to address how these functions of p53 relate to the control of metabolism and disease in vivo. Understanding how the cellular response to metabolic stress is controlled, and identifying a role for p53 in the regulation of metabolic homeostasis has enormous potential to influence the diagnosis and treatment of disease. The proposal will help to define the role of p53 in the development of diabetes and obesity, and lay the groundwork for the investigation of a role for p53 in other pathologies, such as neurodegenerative disease, cardiovascular disease and liver disease. These studies will therefore have far-reaching impact on some of the most prominent health threats in the developed world.
Max ERC Funding
2 437 814 €
Duration
Start date: 2013-02-01, End date: 2018-01-31
Project acronym PACCASA
Project Preventing Abuse of Children in the Context of AIDS
in sub-Saharan Africa
Researcher (PI) Lucie Dale Cluver
Host Institution (HI) THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Call Details Starting Grant (StG), SH3, ERC-2012-StG_20111124
Summary To date, 12 million children have been orphaned by AIDS, and 70 million more live with AIDS-affected caregivers within sub-Saharan Africa. Our programme of research has demonstrated heightened levels of physical, sexual and emotional abuse amongst children in AIDS-affected families. Despite increasing calls for intervention studies addressing child abuse in the developing world (UN 2008; WHO 2010) no interventions or research have yet targeted this high-risk group of AIDS-affected children. This project will develop and test, using a randomised controlled trial design, an evidence-based intervention to prevent and reduce child abuse within AIDS-affected families in South Africa.
The study takes an innovative approach, incorporating a tripartite collaborative process between scientists, policy-makers, and civil society, thus maximising cultural applicability and sustainability. The randomised controlled trial includes 1600 adult and child participants, with wait-list controls and 1-year post-test evaluation in a real-world setting. The research has the key aims of 1) Testing theoretical frameworks of causation and prevention of child abuse in the developing world; 2) Testing the efficacy of an intervention for reducing child abuse; (3) Examining potential intervention moderators and mediators; (4) Testing the feasibility of the intervention when implemented by community volunteers at a low cost; (5) Disseminating results within sub-Saharan Africa to inform policy and programming.
This study capitalises on the PI’s position as a scientific advisor to Southern African governments and international NGOs, on the expertise of a senior advisory group of academics and policy-makers, and on an established research team. This research is of immediate necessity in promoting child development within the world pandemic of HIV/AIDS. It also goes beyond the state of the art in innovation, collaboration, and a commitment to the active engagement of science with civil society.
Summary
To date, 12 million children have been orphaned by AIDS, and 70 million more live with AIDS-affected caregivers within sub-Saharan Africa. Our programme of research has demonstrated heightened levels of physical, sexual and emotional abuse amongst children in AIDS-affected families. Despite increasing calls for intervention studies addressing child abuse in the developing world (UN 2008; WHO 2010) no interventions or research have yet targeted this high-risk group of AIDS-affected children. This project will develop and test, using a randomised controlled trial design, an evidence-based intervention to prevent and reduce child abuse within AIDS-affected families in South Africa.
The study takes an innovative approach, incorporating a tripartite collaborative process between scientists, policy-makers, and civil society, thus maximising cultural applicability and sustainability. The randomised controlled trial includes 1600 adult and child participants, with wait-list controls and 1-year post-test evaluation in a real-world setting. The research has the key aims of 1) Testing theoretical frameworks of causation and prevention of child abuse in the developing world; 2) Testing the efficacy of an intervention for reducing child abuse; (3) Examining potential intervention moderators and mediators; (4) Testing the feasibility of the intervention when implemented by community volunteers at a low cost; (5) Disseminating results within sub-Saharan Africa to inform policy and programming.
This study capitalises on the PI’s position as a scientific advisor to Southern African governments and international NGOs, on the expertise of a senior advisory group of academics and policy-makers, and on an established research team. This research is of immediate necessity in promoting child development within the world pandemic of HIV/AIDS. It also goes beyond the state of the art in innovation, collaboration, and a commitment to the active engagement of science with civil society.
Max ERC Funding
1 460 373 €
Duration
Start date: 2013-06-01, End date: 2019-01-31
Project acronym STRUCT4LEG
Project Structural biology of Legionella’s effectors and secretion system
Researcher (PI) Gabriel Waksman
Host Institution (HI) BIRKBECK COLLEGE - UNIVERSITY OF LONDON
Call Details Advanced Grant (AdG), LS1, ERC-2012-ADG_20120314
Summary Legionella pneumophila is the causative agent of a severe form of pneumonia known as Legionnaires’ disease. Legionella utilizes a type IV secretion system, encoded by the dot/icm gene cluster, to secrete circa 300 effectors that highjack host cellular function to allow the bacterium to live intracellularly inside macrophages. Although the molecular basis of effector function has been elucidated for a small number of effectors, there remain a large number of effectors for which no function has been ascribed. Moreover, when function is known, the host target to which the effector binds has not always been identified. Finally, when effector function and target are known, the molecular basis of effector-target interaction often remains to be determined. This proposal aims to address these issues using a structural biology approach. Another issue addressed by this proposal is the structural and molecular characterisation of the Dot/Icm type IV secretion system responsible for effector secretion through the double membrane of Legionella. Therefore, we propose here three complementary lines of research: i- using a structural biology approach, we will determine the structures of functionally-uncharacterised Legionella effectors in order to derive their function; any function derived from structure will be validated by Professor Craig Roy, a leading researcher in the field of Legionella infection. ii- when/once the effector’s target is known, we will investigate the molecular basis of effector-target interaction by determining the structure of the binary effector-target complexes. iii- we will investigate the structure of the secretion apparatus that is responsible for secreting effectors through the Legionnella membrane. This proposal will greatly enhance our knowledge of the various mechanisms used by pathogenic bacteria to develop intra-cellularly in humans, and provide the basis for drug design efforts aiming at neutralizing Legionella infection.
Summary
Legionella pneumophila is the causative agent of a severe form of pneumonia known as Legionnaires’ disease. Legionella utilizes a type IV secretion system, encoded by the dot/icm gene cluster, to secrete circa 300 effectors that highjack host cellular function to allow the bacterium to live intracellularly inside macrophages. Although the molecular basis of effector function has been elucidated for a small number of effectors, there remain a large number of effectors for which no function has been ascribed. Moreover, when function is known, the host target to which the effector binds has not always been identified. Finally, when effector function and target are known, the molecular basis of effector-target interaction often remains to be determined. This proposal aims to address these issues using a structural biology approach. Another issue addressed by this proposal is the structural and molecular characterisation of the Dot/Icm type IV secretion system responsible for effector secretion through the double membrane of Legionella. Therefore, we propose here three complementary lines of research: i- using a structural biology approach, we will determine the structures of functionally-uncharacterised Legionella effectors in order to derive their function; any function derived from structure will be validated by Professor Craig Roy, a leading researcher in the field of Legionella infection. ii- when/once the effector’s target is known, we will investigate the molecular basis of effector-target interaction by determining the structure of the binary effector-target complexes. iii- we will investigate the structure of the secretion apparatus that is responsible for secreting effectors through the Legionnella membrane. This proposal will greatly enhance our knowledge of the various mechanisms used by pathogenic bacteria to develop intra-cellularly in humans, and provide the basis for drug design efforts aiming at neutralizing Legionella infection.
Max ERC Funding
2 475 317 €
Duration
Start date: 2013-05-01, End date: 2018-04-30